Skip to main content
- Funds
- Insights
- Capabilities
- About Us
- My Account
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
With the current blend of macro headwinds and tailwinds, we believe it is critical to keep a global growth equities portfolio well balanced. As quality-growth investors, we evaluate investments using four factors — quality, growth, valuation upside, and capital return — with varying emphasis based on where we are in the economic cycle. Wellington’s proprietary Global Cycle Index (Figure 1) recently peaked and is trending sideways following the largest economic bounce on record. In this environment, we weight each of our four factors equally as we rank stocks in our investment universe and believe that maintaining higher quality and valuation discipline is essential to navigating today’s volatility.
In this short outlook, we highlight how this market backdrop may impact growth companies, including areas that we think are well positioned for the year ahead.
Firstly, it’s important to evaluate the macro factors currently affecting growth equities. The combination of effective vaccines and treatments against COVID-19, unprecedented government monetary and fiscal stimulus worldwide, and positive consumer confidence drove economic growth this past year.
But the tailwinds from 2021 are now driving headwinds as inflation increases and the US Federal Reserve begins to taper bond purchases in 2022, raising interest rates. Notably, we believe the market will price in more persistent inflation, which may hit a 30-year high in September 2022. We expect economic growth to slow down in the first half of 2022 as higher prices for energy and other goods weigh on consumer confidence and squeeze real incomes unless wages rise enough to support reflation.
In our view, it is crucial to next consider how different growth companies will behave amid these diverse factors.
The effect of rising rates varies significantly across companies and sectors. On the positive side, high-quality growth financials may benefit from exposure to wider interest-rate spreads. For example, wealth management companies can charge higher fees on cash balances, banks’ net interest margins should expand as rates go up, and demand continues to increase for private equity investments that are uncorrelated with public equities.
On the other hand, when interest rates rise, valuation discipline becomes even more important, in our view. This is particularly true when investing in growth equities. Higher rates impact more expensive, higher-multiple stocks as their cost of capital rises. For instance, we see examples of this among some technology stocks. This is one reason why we view that valuation discipline is an essential input into our process. We typically look for stocks to have a minimum of 10% valuation upside potential and also seek to avoid exaggerated free-cash-flow yield valuation multiples. In addition, companies with more balance-sheet leverage and emerging markets countries with high levels of dollar-denominated debt may struggle in a higher-interest-rate environment. Our focus on high-quality companies generating strong free-cash-flow margins with low debt levels is therefore especially important in this environment.
Similarly, the impacts of inflationary pressures range widely across companies and sectors. Some can absorb higher cost inputs without sacrificing margins because they have the pricing power to pass these costs on to their customers. Such companies usually exist in the software and services, health care, data analytics, and industrials sectors. In our view, these businesses are attractive in this environment as they have pricing power because their products and services are unique and high value, improve efficiency, lower costs, and are mission critical for their customers.
Conversely, companies that sell products that are less differentiated or lower value-add may lack pricing power, particularly given the price transparency available online. For example, consumer staples companies are more vulnerable to today’s rising inflationary pressures. These companies absorb higher raw material and transportation costs without fully passing these costs on to their customers, resulting in lower margins. Wage inflation also puts margin pressure on companies with high labor costs, such as those in the consumer services or consulting sectors. Notably, leading companies with global scale are less susceptible to wage inflation as they have better technology platforms to hire and train people and recruit from different countries, which is more difficult for smaller companies.
Lastly, we believe China offers strong economic growth potential and investment opportunities in 2022. The country tightened liquidity with increased regulations during 2021. As a result, China’s increase in economic growth was low relative to other major countries, and its equities lagged. However, we believe China may still be offering investment opportunities and attractive valuations, as we expect the government to stimulate the economy in 2022 while the rest of the world tightens. Furthermore, we anticipate that China’s regulatory activity seen this past year will slow down.
In particular, we like consumer, internet, and health care companies in China as we think these sectors may benefit from secular government support for growth as well as an emerging middle class with discretionary income to spend on goods and services.
Today’s markets are influenced by strong macroeconomic forces, including government stimulus, rising interest rates, inflation, and regulation. As growth equity investors, we find it easier to navigate this volatile environment by adhering to our disciplined, structured philosophy and process. Looking to 2022 and beyond, we believe this approach to identifying potential companies with high quality, growth potential, valuation upside, and capital return to shareholders is especially important in this market.
Strong fundamentals, attractive valuations: Why the time may be right for active biotech investing
From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run.
Beyond US large cap: Where now for equity investors?
How should investors navigate a narrow market? Looking ahead to the rest of the year, Macro Strategist Nicolas Wylenzek examines the structural backdrop and Equity Strategist Andrew Heiskell shares his view on equity opportunities to watch.
What could change the trajectory of value stocks?
Head of Multi-Asset Strategy Adam Berger and Equity Portfolio Manager Nataliya Kofman discuss “resilient” value stocks, disruptive themes, and attractive sector- and country-level opportunities.
Small-cap stocks: Watching for mean reversion, technology diffusion, and the next inflection point
Our experts discuss factors that could help small-cap stocks rebound and the search for winners in this inefficient segment of the market.
4 equity themes: Budding opportunities in small caps and more
Our expert highlights 4 areas where he sees opportunity in global equity markets.
A turning point for US small caps
Myth busting US small caps: why now could be a compelling entry point for the asset class.
Will a “Goldilocks” economy be just right for equity markets?
We provide an outlook on the ongoing shift to new investment regime, and the market segments that we expect will most heavily influence global equity performance in the coming year.
Why investing in themes for EM equities may reap rewards
Portfolio Manager Dáire Dunne outlines why he is increasingly optimistic about the potential opportunities within select EM equity themes this year.
Small-cap value: Strong past, bright future?
While equity markets have had a challenging recent past, history teaches us that there may be several reasons to be optimistic about small-cap value.
URL References
Related Insights
Equity Market Outlook
In our Equity Market Outlook, we offer a range of fundamental, factor, and sector insights.
Multiple authors